Cost-of-disease in heart failure in Turkey: a delphi panel based analysis of direct costs
Yükleniyor...
Tarih
2022
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Elsevier
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Objectives: To determine the indirect cost of heart failure (HF) in Turkey from loss of
labor force perspective. Methods: Indirect cost of HF was determined based on
epidemiological and loss of work productivity data provided by a Delphi panel
consisted of 11 experts in HF. The results are weighted by the distribution of the
patients due to NYHA classes and ejection fraction status. Estimates of lost productivity, involving data on loss of labor due to absenteeism –percentage worktime
missed due to disease– plus presenteeism –decreased productivity due to disease while
at work– was provided using a modified version Work Productivity and Activity
Impairment Questionnaire: General Health (WPAI:GH). Indirect costs were calculated based on the average age-and-gender-adjusted wage statistics and lost productivity due to absenteeism and presenteeism. Local costs are collected in Turkish
Lira (TL) and converted to Euro (V), based on V/TL currency rate of 9.0073 on 15th
March 2021. Results: The overall proportion of patients not currently working was
52%. Overall absenteeism, presenteeism and total work impairment was 15%, 38%
and 45%, respectively. The proportion of patients not working, and overall absenteeism, presenteeism and total work impairment showed a steep increase with
advancing NYHA classes. Per patient annual loss of labor, caused by nonworking HF
patients, was calculated as V1,622. Further losses due to absenteeism and presenteeism were V463 and V1,247, respectively. Total lost productivity, which is
V3,332 per patient, increased from V1,290 in NYHA-I class to V2,678, V5,232 and
V6,155 in NYHA-II, NYHA-III and NYHA-IV classes, respectively. Conclusions: Our
findings confirm the substantial economic loss of labor force in HF patients.
Advanced NYHA stage seems to be associated with likelihood of cost increments
related to indirect expenses. Thus, implementation of measures to delay disease
progression could prevent loss of productivity and decrease indirect costs in HF.
Açıklama
Anahtar Kelimeler
Kaynak
Value in Health
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
25
Sayı
1
Künye
Çavuşoğlu, Y., Altay, H., Aras, D., Çelik, A., Dinç, M., Aktaş, F., Kılıçaslan, B., Nalbantgil, S., Özdemir, O., Özsoy, A., Temizhan, A., Ural, D., Yıldırımtürk, O., & Yılmaz, M. (2022). Cost-of-disease in heart failure in Turkey: a delphi panel based analysis of direct costs. Value in Health, 25(1), S119-S119. https://doi.org/10.1016/j.jval.2021.11.566
